Literature DB >> 23159230

Risk of myocardial infarction in patients with rhinosinusitis.

Wen-Rui Hao1, Hui-Wen Lin, Pin-Zhir Chao, Chin-Wen Wu, Tze-Hsun Yen, Ju-Chi Liu, Tsan-Hon Liou.   

Abstract

Research has indicated that inflammation promote all phases of atherosclerosis. The current study tested the hypothesis that rhinosinusitis is a risk marker for myocardial infarction (MI). Data on the general population were obtained from the Taiwan Longitudinal Health Insurance Database 2005 (LHID2005). The study cohort comprised patients who had received a recorded diagnosis of rhinosinusitis (N = 52,930) between January 1, 2004 and December 31, 2004. The comparison group consisted of patients who had not received a rhinosinusitis diagnosis, and who were matched for age and sex with the study group at a ratio of 4 controls to 1 study patient (1:4) (N = 211,720). Each patient's condition was followed using database entries until the end of 2006. Cox proportional hazard regressions were used to evaluate the 3-year MI-free survival rates, after adjusting for known confounding factors. We found that patients with rhinosinusitis were more likely than the control group to have MI, after adjusting for potential confounders [adjusted hazard ratio (HR), 1.84; 95% confidence interval (CI), 1.44 ∼ 2.40]. Of the total 264 650 patients, 290 experienced MI during the 3-year follow-up period, including 8 acute sinusitis patients, 77 chronic sinusitis patients, and 205 control patients. The incidence rate of MI was 6.19 (95% CI 5.01-7.65) per 10,000 person-years for rhinosinusitis patients, compared to 3.51 (95% CI, 3.06-4.02) for the control patients. From this study, rhinosinusitis may be associated with MI. Further research in this important area of public health is warranted.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23159230     DOI: 10.1016/j.atherosclerosis.2012.10.058

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Five-year risk of incident disease following a diagnosis of chronic rhinosinusitis.

Authors:  A G Hirsch; X S Yan; A S Sundaresan; B K Tan; R P Schleimer; R C Kern; T L Kennedy; J S Greene; B S Schwartz
Journal:  Allergy       Date:  2015-09-25       Impact factor: 13.146

Review 2.  The association of premorbid diseases with chronic rhinosinusitis with and without polyps.

Authors:  Kent Lam; Annemarie G Hirsch; Bruce K Tan
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2014-06       Impact factor: 2.064

3.  Chronic bronchitis without airflow obstruction, asthma and rhinitis are differently associated with cardiovascular risk factors and diseases.

Authors:  Marcello Ferrari; Elia Piccinno; Alessandro Marcon; Pierpaolo Marchetti; Lucia Cazzoletti; Pietro Pirina; Salvatore Battaglia; Amelia Grosso; Giulia Squillacioti; Leonardo Antonicelli; Giuseppe Verlato; Giancarlo Pesce
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

Review 4.  Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden.

Authors:  Achim Beule
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 5.  The Role of Blood Viscosity in Infectious Diseases.

Authors:  Gregory D Sloop; Quirijn De Mast; Gheorghe Pop; Joseph J Weidman; John A St Cyr
Journal:  Cureus       Date:  2020-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.